Sacubitril/Valsartan
ARNI (Angiotensin Receptor-Neprilysin Inhibitor)
Brand names: Entresto, ENTRESTO
Oral
Mechanism of Action
Dual inhibition: sacubitril inhibits neprilysin (increasing natriuretic peptides) while valsartan blocks AT1 receptors.
Indications
Heart Failure with Reduced Ejection Fraction
Known Side Effects
0 documented side effects by frequency
No structured side effect data available.
Community Discussions
No community discussions found for Sacubitril/Valsartan yet.
Compare With
0 available comparisons
No comparisons yet.
Formulations
Dosage Forms
Tablet
Route
Oral